Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

The EORTC CAT Core-The computer adaptive version of the EORTC QLQ-C30 questionnaire

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Antiemetic use of olanzapine in patients with advanced cancer: results from an open-label multicenter study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. The Female Sexual Function Index (FSFI)-A Systematic Review of Measurement Properties

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  • Morten Aa Petersen
  • Neil K Aaronson
  • Juan I Arraras
  • Wei-Chu Chie
  • Thierry Conroy
  • Anna Costantini
  • Linda Dirven
  • Peter Fayers
  • Eva-Maria Gamper
  • Johannes M Giesinger
  • Esther J J Habets
  • Eva Hammerlid
  • Jorunn Helbostad
  • Marianne J Hjermstad
  • Bernhard Holzner
  • Colin Johnson
  • Georg Kemmler
  • Madeleine T King
  • Stein Kaasa
  • Jon H Loge
  • Jaap C Reijneveld
  • Susanne Singer
  • Martin J B Taphoorn
  • Lise H Thamsborg
  • Krzysztof A Tomaszewski
  • Galina Velikova
  • Irma M Verdonck-de Leeuw
  • Teresa Young
  • Mogens Groenvold
Vis graf over relationer

BACKGROUND: To optimise measurement precision, relevance to patients and flexibility, patient-reported outcome measures (PROMs) should ideally be adapted to the individual patient/study while retaining direct comparability of scores across patients/studies. This is achievable using item banks and computerised adaptive tests (CATs). The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 (QLQ-C30) is one of the most widely used PROMs in cancer research and clinical practice. Here we provide an overview of the research program to develop CAT versions of the QLQ-C30's 14 functional and symptom domains.

METHODS: The EORTC Quality of Life Group's strategy for developing CAT item banks consists of: literature search to identify potential candidate items; formulation of new items compatible with the QLQ-C30 item style; expert evaluations and patient interviews; field-testing and psychometric analyses, including factor analysis, item response theory calibration and simulation of measurement properties. In addition, software for setting up, running and scoring CAT has been developed.

RESULTS: Across eight rounds of data collections, 9782 patients were recruited from 12 countries for the field-testing. The four phases of development resulted in a total of 260 unique items across the 14 domains. Each item bank consists of 7-34 items. Psychometric evaluations indicated higher measurement precision and increased statistical power of the CAT measures compared to the QLQ-C30 scales. Using CAT, sample size requirements may be reduced by approximately 20-35% on average without loss of power.

CONCLUSIONS: The EORTC CAT Core represents a more precise, powerful and flexible measurement system than the QLQ-C30. It is currently being validated in a large independent, international sample of cancer patients.

OriginalsprogEngelsk
TidsskriftEuropean journal of cancer (Oxford, England : 1990)
Vol/bind100
Sider (fra-til)8-16
Antal sider9
ISSN0959-8049
DOI
StatusUdgivet - sep. 2018

ID: 55594715